“At one year from initiation of TAM, plasma measurements show that a substantial proportion of premenopausal patients are not adequately adherent to this treatment. Poorly-adherent patients could benefit from metabolic and pharmacogenetic investigations. Identification of [more]
There is too little awareness about cancer associated thrombosis: this is the main result of the first survey on awareness of cancer related thrombosis presented by ECPC (the European Cancer Patient Coalition) for the World Thrombosis [more]
American James Allison and Japanese Tasuku Honjo have been awarded the 2018 Nobel Prize for Physiology or Medicine thanks to their findings leading to recent new approaches in cancer treatment. James Allison, born in Texas [more]
The most commonly prescribed class of immunotherapies (called ICIs, immune checkpoint inhibitors) are not free from fulminant and fatal toxic side effects; the researchers of the Vanderbilt-Ingram Cancer Center recently evaluated their toxicities, publishing the [more]
On Tuesday 11th of September Catalonia (Spain) celebrated its ‘National Day’. Hundreds of thousands Catalans in favor of independence filled the streets, wearing yellow ribbons: the symbol they are using for claiming freedom for the [more]
Over 20 specialised centres that will be open to the public, and events in ten cities will be part of the Italian effort to raise public awareness on early diagnosis in head and neck cancers, [more]
Among patients hospitalised for advanced lung cancer, the prescription of preventative medicines for diabetes, hypertension, hyperlipidemia, antiplatelet agents, and vitamins/minerals is very common not only at the moment of admission, but also at discharge, according [more]
Physicians seem to accommodate to patients’ requests of second opinions trying not to harm neither the relationship with patients themselves nor with colleagues. Oncologists usually cooperate among each other, even though they do not often [more]
For many patients newly diagnosed with cancer, financial toxicity should be on top of the list of their doctors concerns: according to a US survey described on the peer-reviewed journal Cancer, published by the American Cancer [more]
A blood test that can predict how men with advanced prostate cancer will respond to specific treatments has been validated in a multi-institution cohort study, recently published on Jama Oncology by an International group coordinated [more]
Cancer patients who use complementary medicine tend to refuse effective treatments more often than non users, and this reflects on increased mortality: this is the conclusion of an observational study just published on Jama Oncology, that [more]
A research letter just published in the journal Nature by an International group of researchers directed by Grace Collord of the Wellcome Sanger Institute and University of Cambridge, in England, “provides proof-of-principle that it may be possible to develop [more]
The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO) are worried by the “tsunami of future cancer cases that will drain our health systems and our economies”, and call [more]